Search

Search Constraints

You searched for: Author/Creator Meng, Lisa

Search Results

1. A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS. Issue 3 (3rd April 2021)

2. A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis. Issue 7 (2nd October 2019)

6. Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HF. (3rd March 2022)

7. Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N‐terminal pro‐B‐type natriuretic peptide level: insights from the GALACTIC‐HF trial. (16th January 2023)

9. Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS. (31st December 2023)